Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The Xenopus c-mos proto-oncogene product, Mosxe, possesses cytostatic factor (CSF) activity to arrest maturing oocytes in metaphase II and has weak transforming activity in mouse NIH3T3 cells. We show that Mosxe mutants bearing 'stabilizing' penultimate N-terminal amino acids are strongly transforming and can retard progression through the G2-M phases in Mosxe-transformed cells, probably via their CSF activity. On the other hand, a cyclin-Mosxe fusion protein, which undergoes abrupt degradation at the end of mitosis and is restored to its normal levels only after the G1 phase, transforms cells much less efficiently than a mutated cyclin-Mosxe fusion protein that is stable during M-G1 transition. Moreover, in low-serum medium, cells transformed by the unstable cyclin-Mosxe require a long period to enter the S phase, in contrast with the rapid entry into the S phase of cells transformed by the stable cyclin-Mosxe. These results provide strong evidence that unlike the physiological CSF activity, the transforming activity of Mos is exerted in the G1 phase of the cell cycle.
Bernard,
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.
1983, Pubmed
Bernard,
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.
1983,
Pubmed Bishop,
Molecular themes in oncogenesis.
1991,
Pubmed Blose,
10-nm filaments are induced to collapse in living cells microinjected with monoclonal and polyclonal antibodies against tubulin.
1984,
Pubmed Bold,
Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors.
1985,
Pubmed Cantley,
Oncogenes and signal transduction.
1991,
Pubmed Chackalaparampil,
Altered phosphorylation and activation of pp60c-src during fibroblast mitosis.
1988,
Pubmed Ciechanover,
Degradation of nuclear oncoproteins by the ubiquitin system in vitro.
1991,
Pubmed Cross,
Growth factors in development, transformation, and tumorigenesis.
1991,
Pubmed DePinho,
Structure and expression of the murine N-myc gene.
1986,
Pubmed Doppler,
Induction of v-mos and activated Ha-ras oncogene expression in quiescent NIH 3T3 cells causes intracellular alkalinisation and cell-cycle progression.
1987,
Pubmed Draetta,
Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF.
1989,
Pubmed Evans,
Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.
1983,
Pubmed Fischinger,
Quantitative interactions of feline leukaemia virus and its pseudotype of murine sarcoma virus in cat cells: requirement for DNA synthesis.
1971,
Pubmed Freeman,
Effects of the v-mos oncogene on Xenopus development: meiotic induction in oocytes and mitotic arrest in cleaving embryos.
1990,
Pubmed
,
Xenbase Freeman,
Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes.
1989,
Pubmed
,
Xenbase Gautier,
Cyclin is a component of maturation-promoting factor from Xenopus.
1990,
Pubmed
,
Xenbase Glotzer,
Cyclin is degraded by the ubiquitin pathway.
1991,
Pubmed
,
Xenbase Goldman,
Expression of c-mos RNA in germ cells of male and female mice.
1987,
Pubmed Graham,
A new technique for the assay of infectivity of human adenovirus 5 DNA.
1973,
Pubmed Huang,
Specificity of cotranslational amino-terminal processing of proteins in yeast.
1987,
Pubmed Hunt,
Embryology. Under arrest in the cell cycle.
1989,
Pubmed
,
Xenbase Hunt,
Cell biology. Destruction's our delight..
1991,
Pubmed Hunter,
Cooperation between oncogenes.
1991,
Pubmed Hunter,
Cyclins and cancer.
1991,
Pubmed Karsenti,
Interconversion of metaphase and interphase microtubule arrays, as studied by the injection of centrosomes and nuclei into Xenopus eggs.
1984,
Pubmed
,
Xenbase Keshet,
Developmental regulation of ovarian-specific Mos expression.
1988,
Pubmed Liu,
Cell cycle-mediated structural and functional alteration of P85gag-mos protein kinase activity.
1990,
Pubmed Masui,
Oocyte maturation.
1979,
Pubmed Masui,
Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes.
1971,
Pubmed Maxwell,
Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos.
1985,
Pubmed Minshull,
Translation of cyclin mRNA is necessary for extracts of activated xenopus eggs to enter mitosis.
1989,
Pubmed
,
Xenbase Morgan,
Mitosis-specific phosphorylation of p60c-src by p34cdc2-associated protein kinase.
1989,
Pubmed
,
Xenbase Murray,
The role of cyclin synthesis and degradation in the control of maturation promoting factor activity.
1989,
Pubmed
,
Xenbase Mutter,
Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells.
1987,
Pubmed Nishizawa,
The 'second-codon rule' and autophosphorylation govern the stability and activity of Mos during the meiotic cell cycle in Xenopus oocytes.
1992,
Pubmed
,
Xenbase Nurse,
Universal control mechanism regulating onset of M-phase.
1990,
Pubmed Okazaki,
Correlation between physiological and transforming activities of the c-mos proto-oncogene product and identification of an essential Mos domain for these activities.
1991,
Pubmed
,
Xenbase O'Keefe,
The c-mos gene product is required for cyclin B accumulation during meiosis of mouse eggs.
1991,
Pubmed O'Keefe,
Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg.
1989,
Pubmed Oskarsson,
Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus.
1980,
Pubmed Papkoff,
Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus.
1982,
Pubmed Papkoff,
The transforming protein of Moloney murine sarcoma virus is a soluble cytoplasmic protein.
1983,
Pubmed Pardee,
G1 events and regulation of cell proliferation.
1989,
Pubmed Paules,
Mouse Mos protooncogene product is present and functions during oogenesis.
1989,
Pubmed
,
Xenbase Perricaudet,
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.
1979,
Pubmed Propst,
Expression of c-mos proto-oncogene transcripts in mouse tissues.
,
Pubmed Rechavi,
Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element.
1982,
Pubmed Reddy,
Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus.
1980,
Pubmed Rogers,
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.
1986,
Pubmed Roy,
The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product.
1990,
Pubmed
,
Xenbase Sagata,
The product of the mos proto-oncogene as a candidate "initiator" for oocyte maturation.
1989,
Pubmed
,
Xenbase Sagata,
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs.
1989,
Pubmed
,
Xenbase Sagata,
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes.
1988,
Pubmed
,
Xenbase Schmidt,
Chicken homolog of the mos proto-oncogene.
1988,
Pubmed Shenoy,
Purified maturation promoting factor phosphorylates pp60c-src at the sites phosphorylated during fibroblast mitosis.
1989,
Pubmed
,
Xenbase Southern,
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
1982,
Pubmed Taylor,
The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA.
1985,
Pubmed Van Beveren,
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini.
1983,
Pubmed Van Beveren,
FBR murine osteosarcoma virus. II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes.
1984,
Pubmed Van Beveren,
Nucleotide sequence of the genome of a murine sarcoma virus.
1981,
Pubmed Vande Woude,
mos proto-oncogene function.
1990,
Pubmed
,
Xenbase Warren,
Elevated expression of pp60c-src alters a selective morphogenetic property of epithelial cells in vitro without a mitogenic effect.
1988,
Pubmed Watanabe,
Independent inactivation of MPF and cytostatic factor (Mos) upon fertilization of Xenopus eggs.
1991,
Pubmed
,
Xenbase Watanabe,
Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs.
1989,
Pubmed
,
Xenbase Watson,
Nucleotide sequence analysis of the chicken c-myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, delta gag-myc.
1983,
Pubmed Yasuda,
A point mutation in C-terminal region of cdc2 kinase causes a G2-phase arrest in a mouse temperature-sensitive FM3A cell mutant.
1991,
Pubmed Yew,
mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities.
1991,
Pubmed
,
Xenbase Zhou,
Ability of the c-mos product to associate with and phosphorylate tubulin.
1991,
Pubmed
,
Xenbase
